InvaGen Pharmaceuticals Inc Discontinued
FDA Approved Drugs

InvaGen Pharmaceuticals Inc Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 63
  • Latest Approval Date May 14, 2025
  • Data Source FDA
  • First Approval Date Jun 12, 2007
All
170
View
Unclassified
2
View
Discontinued
63
View
RX
105
View
Company Overview

Company

InvaGen Pharmaceuticals Inc Discontinued

Country

U.S.A

Website

Visit Website

Email

Social Profiles

Company Snapshot

InvaGen Pharmaceuticals Inc Discontinued

7 Oser Avenue ,Hauppauge, NY 11788

U.S.A

www.invagen.com/ View on Map
FDA Approved Drug Records ( 63 records )
2016
30 Sep
Discontinued Application: 207570

Drug Name

AMANTADINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2016-09-30

207570 / 1

Active Ingredient

AMANTADINE HYDROCHLORIDE

Application Number

207570

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2016-09-30

Regulatory Status

Discontinued

2017
31 Jan
Discontinued Application: 207571

Drug Name

AMANTADINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2017-01-31

207571 / 1

Active Ingredient

AMANTADINE HYDROCHLORIDE

Application Number

207571

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2017-01-31

Regulatory Status

Discontinued

2017
09 Jan
Discontinued Application: 204846

Drug Name

ATORVASTATIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2017-01-09

204846 / 1

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

204846

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2017-01-09

Regulatory Status

Discontinued

2017
09 Jan
Discontinued Application: 204846

Drug Name

ATORVASTATIN CALCIUM

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2017-01-09

204846 / 2

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

204846

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2017-01-09

Regulatory Status

Discontinued

2017
09 Jan
Discontinued Application: 204846

Drug Name

ATORVASTATIN CALCIUM

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2017-01-09

204846 / 3

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

204846

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2017-01-09

Regulatory Status

Discontinued

2017
09 Jan
Discontinued Application: 204846

Drug Name

ATORVASTATIN CALCIUM

Product Number

4

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2017-01-09

204846 / 4

Active Ingredient

ATORVASTATIN CALCIUM

Application Number

204846

Product Number

4

Dosage Form

-

Strength

EQ 80MG BASE

Approval Date

2017-01-09

Regulatory Status

Discontinued

2010
29 Mar
Discontinued Application: 90294

Drug Name

BENZTROPINE MESYLATE

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2010-03-29

90294 / 1

Active Ingredient

BENZTROPINE MESYLATE

Application Number

90294

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

2010-03-29

Regulatory Status

Discontinued

2010
29 Mar
Discontinued Application: 90294

Drug Name

BENZTROPINE MESYLATE

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2010-03-29

90294 / 2

Active Ingredient

BENZTROPINE MESYLATE

Application Number

90294

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

2010-03-29

Regulatory Status

Discontinued

2010
29 Mar
Discontinued Application: 90294

Drug Name

BENZTROPINE MESYLATE

Product Number

3

Dosage Form

-

Strength

2MG

Approval Date

2010-03-29

90294 / 3

Active Ingredient

BENZTROPINE MESYLATE

Application Number

90294

Product Number

3

Dosage Form

-

Strength

2MG

Approval Date

2010-03-29

Regulatory Status

Discontinued

2016
26 Aug
Discontinued Application: 206556

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2016-08-26

206556 / 1

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

206556

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2016-08-26

Regulatory Status

Discontinued

2016
26 Aug
Discontinued Application: 206556

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2016-08-26

206556 / 2

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

206556

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2016-08-26

Regulatory Status

Discontinued

2016
09 Feb
Discontinued Application: 206674

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2016-02-09

206674 / 1

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

206674

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2016-02-09

Regulatory Status

Discontinued

2016
09 Feb
Discontinued Application: 206674

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2016-02-09

206674 / 2

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

206674

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2016-02-09

Regulatory Status

Discontinued

2016
09 Feb
Discontinued Application: 206674

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2016-02-09

206674 / 3

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

206674

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2016-02-09

Regulatory Status

Discontinued

2017
18 Sep
Discontinued Application: 207389

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2017-09-18

207389 / 1

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

207389

Product Number

1

Dosage Form

-

Strength

75MG

Approval Date

2017-09-18

Regulatory Status

Discontinued

2017
18 Sep
Discontinued Application: 207389

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2017-09-18

207389 / 2

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

207389

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2017-09-18

Regulatory Status

Discontinued

2020
20 Apr
Discontinued Application: 212602

Drug Name

COLESEVELAM HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

625MG

Approval Date

2020-04-20

212602 / 1

Active Ingredient

COLESEVELAM HYDROCHLORIDE

Application Number

212602

Product Number

1

Dosage Form

-

Strength

625MG

Approval Date

2020-04-20

Regulatory Status

Discontinued

2017
28 Mar
Discontinued Application: 207378

Drug Name

FENOFIBRATE (MICRONIZED)

Product Number

1

Dosage Form

-

Strength

67MG

Approval Date

2017-03-28

207378 / 1

Active Ingredient

FENOFIBRATE

Application Number

207378

Product Number

1

Dosage Form

-

Strength

67MG

Approval Date

2017-03-28

Regulatory Status

Discontinued

2017
28 Mar
Discontinued Application: 207378

Drug Name

FENOFIBRATE (MICRONIZED)

Product Number

2

Dosage Form

-

Strength

134MG

Approval Date

2017-03-28

207378 / 2

Active Ingredient

FENOFIBRATE

Application Number

207378

Product Number

2

Dosage Form

-

Strength

134MG

Approval Date

2017-03-28

Regulatory Status

Discontinued

2017
28 Mar
Discontinued Application: 207378

Drug Name

FENOFIBRATE (MICRONIZED)

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2017-03-28

207378 / 3

Active Ingredient

FENOFIBRATE

Application Number

207378

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2017-03-28

Regulatory Status

Discontinued

2012
16 Oct
Discontinued Application: 202764

Drug Name

GABAPENTIN

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2012-10-16

202764 / 1

Active Ingredient

GABAPENTIN

Application Number

202764

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2012-10-16

Regulatory Status

Discontinued

2012
16 Oct
Discontinued Application: 202764

Drug Name

GABAPENTIN

Product Number

2

Dosage Form

-

Strength

800MG

Approval Date

2012-10-16

202764 / 2

Active Ingredient

GABAPENTIN

Application Number

202764

Product Number

2

Dosage Form

-

Strength

800MG

Approval Date

2012-10-16

Regulatory Status

Discontinued

2008
15 Dec
Discontinued Application: 90255

Drug Name

HYDRALAZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2008-12-15

90255 / 1

Active Ingredient

HYDRALAZINE HYDROCHLORIDE

Application Number

90255

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2008-12-15

Regulatory Status

Discontinued

2008
15 Dec
Discontinued Application: 90255

Drug Name

HYDRALAZINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2008-12-15

90255 / 2

Active Ingredient

HYDRALAZINE HYDROCHLORIDE

Application Number

90255

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2008-12-15

Regulatory Status

Discontinued

2008
15 Dec
Discontinued Application: 90255

Drug Name

HYDRALAZINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2008-12-15

90255 / 3

Active Ingredient

HYDRALAZINE HYDROCHLORIDE

Application Number

90255

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2008-12-15

Regulatory Status

Discontinued

2008
15 Dec
Discontinued Application: 90255

Drug Name

HYDRALAZINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2008-12-15

90255 / 4

Active Ingredient

HYDRALAZINE HYDROCHLORIDE

Application Number

90255

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2008-12-15

Regulatory Status

Discontinued

2009
15 Jan
Discontinued Application: 78234

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2009-01-15

78234 / 1

Active Ingredient

LEVETIRACETAM

Application Number

78234

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2009-01-15

Regulatory Status

Discontinued

2009
15 Jan
Discontinued Application: 78234

Drug Name

LEVETIRACETAM

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2009-01-15

78234 / 2

Active Ingredient

LEVETIRACETAM

Application Number

78234

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2009-01-15

Regulatory Status

Discontinued

2009
15 Jan
Discontinued Application: 78234

Drug Name

LEVETIRACETAM

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2009-01-15

78234 / 3

Active Ingredient

LEVETIRACETAM

Application Number

78234

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2009-01-15

Regulatory Status

Discontinued

2022
17 Feb
Discontinued Application: 200432

Drug Name

MECLIZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2022-02-17

200432 / 1

Active Ingredient

MECLIZINE HYDROCHLORIDE

Application Number

200432

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2022-02-17

Regulatory Status

Discontinued

2022
17 Feb
Discontinued Application: 200432

Drug Name

MECLIZINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2022-02-17

200432 / 2

Active Ingredient

MECLIZINE HYDROCHLORIDE

Application Number

200432

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2022-02-17

Regulatory Status

Discontinued

2022
17 Feb
Discontinued Application: 200432

Drug Name

MECLIZINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2022-02-17

200432 / 3

Active Ingredient

MECLIZINE HYDROCHLORIDE

Application Number

200432

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2022-02-17

Regulatory Status

Discontinued

2022
17 Feb
Discontinued Application: 200791

Drug Name

MECLIZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2022-02-17

200791 / 1

Active Ingredient

MECLIZINE HYDROCHLORIDE

Application Number

200791

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2022-02-17

Regulatory Status

Discontinued

2011
24 Aug
Discontinued Application: 91305

Drug Name

NAPROXEN

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2011-08-24

91305 / 1

Active Ingredient

NAPROXEN

Application Number

91305

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2011-08-24

Regulatory Status

Discontinued

2011
24 Aug
Discontinued Application: 91305

Drug Name

NAPROXEN

Product Number

2

Dosage Form

-

Strength

375MG

Approval Date

2011-08-24

91305 / 2

Active Ingredient

NAPROXEN

Application Number

91305

Product Number

2

Dosage Form

-

Strength

375MG

Approval Date

2011-08-24

Regulatory Status

Discontinued

2011
24 Aug
Discontinued Application: 91305

Drug Name

NAPROXEN

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

2011-08-24

91305 / 3

Active Ingredient

NAPROXEN

Application Number

91305

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

2011-08-24

Regulatory Status

Discontinued

2014
05 Feb
Discontinued Application: 202846

Drug Name

PHENTERMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

37.5MG

Approval Date

2014-02-05

202846 / 1

Active Ingredient

PHENTERMINE HYDROCHLORIDE

Application Number

202846

Product Number

1

Dosage Form

-

Strength

37.5MG

Approval Date

2014-02-05

Regulatory Status

Discontinued

2014
14 Feb
Discontinued Application: 202858

Drug Name

PHENTERMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2014-02-14

202858 / 1

Active Ingredient

PHENTERMINE HYDROCHLORIDE

Application Number

202858

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2014-02-14

Regulatory Status

Discontinued

2014
14 Feb
Discontinued Application: 202858

Drug Name

PHENTERMINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2014-02-14

202858 / 2

Active Ingredient

PHENTERMINE HYDROCHLORIDE

Application Number

202858

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2014-02-14

Regulatory Status

Discontinued

2014
05 Feb
Discontinued Application: 202942

Drug Name

PHENTERMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

37.5MG

Approval Date

2014-02-05

202942 / 1

Active Ingredient

PHENTERMINE HYDROCHLORIDE

Application Number

202942

Product Number

1

Dosage Form

-

Strength

37.5MG

Approval Date

2014-02-05

Regulatory Status

Discontinued

2014
05 May
Discontinued Application: 204414

Drug Name

PHENTERMINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2014-05-05

204414 / 1

Active Ingredient

PHENTERMINE HYDROCHLORIDE

Application Number

204414

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2014-05-05

Regulatory Status

Discontinued

2007
24 Aug
Discontinued Application: 78457

Drug Name

QUINAPRIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2007-08-24

78457 / 1

Active Ingredient

QUINAPRIL HYDROCHLORIDE

Application Number

78457

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2007-08-24

Regulatory Status

Discontinued

2007
24 Aug
Discontinued Application: 78457

Drug Name

QUINAPRIL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2007-08-24

78457 / 2

Active Ingredient

QUINAPRIL HYDROCHLORIDE

Application Number

78457

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2007-08-24

Regulatory Status

Discontinued

2007
24 Aug
Discontinued Application: 78457

Drug Name

QUINAPRIL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2007-08-24

78457 / 3

Active Ingredient

QUINAPRIL HYDROCHLORIDE

Application Number

78457

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2007-08-24

Regulatory Status

Discontinued

2007
24 Aug
Discontinued Application: 78457

Drug Name

QUINAPRIL HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2007-08-24

78457 / 4

Active Ingredient

QUINAPRIL HYDROCHLORIDE

Application Number

78457

Product Number

4

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2007-08-24

Regulatory Status

Discontinued

2011
20 Apr
Discontinued Application: 201356

Drug Name

QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

12.5MG;EQ 10MG BASE

Approval Date

2011-04-20

201356 / 1

Active Ingredient

HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

Application Number

201356

Product Number

1

Dosage Form

-

Strength

12.5MG;EQ 10MG BASE

Approval Date

2011-04-20

Regulatory Status

Discontinued

2011
20 Apr
Discontinued Application: 201356

Drug Name

QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

12.5MG;EQ 20MG BASE

Approval Date

2011-04-20

201356 / 2

Active Ingredient

HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

Application Number

201356

Product Number

2

Dosage Form

-

Strength

12.5MG;EQ 20MG BASE

Approval Date

2011-04-20

Regulatory Status

Discontinued

2011
20 Apr
Discontinued Application: 201356

Drug Name

QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

25MG;EQ 20MG BASE

Approval Date

2011-04-20

201356 / 3

Active Ingredient

HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

Application Number

201356

Product Number

3

Dosage Form

-

Strength

25MG;EQ 20MG BASE

Approval Date

2011-04-20

Regulatory Status

Discontinued

2025
14 May
Discontinued Application: 208543

Drug Name

RIVAROXABAN

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-05-14

208543 / 1

Active Ingredient

RIVAROXABAN

Application Number

208543

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-05-14

Regulatory Status

Discontinued

2025
14 May
Discontinued Application: 208543

Drug Name

RIVAROXABAN

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2025-05-14

208543 / 2

Active Ingredient

RIVAROXABAN

Application Number

208543

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2025-05-14

Regulatory Status

Discontinued

2025
14 May
Discontinued Application: 208543

Drug Name

RIVAROXABAN

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2025-05-14

208543 / 3

Active Ingredient

RIVAROXABAN

Application Number

208543

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2025-05-14

Regulatory Status

Discontinued

2013
01 Jul
Discontinued Application: 204339

Drug Name

RIZATRIPTAN BENZOATE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2013-07-01

204339 / 1

Active Ingredient

RIZATRIPTAN BENZOATE

Application Number

204339

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2013-07-01

Regulatory Status

Discontinued

2013
01 Jul
Discontinued Application: 204339

Drug Name

RIZATRIPTAN BENZOATE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2013-07-01

204339 / 2

Active Ingredient

RIZATRIPTAN BENZOATE

Application Number

204339

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2013-07-01

Regulatory Status

Discontinued

2024
12 Jul
Discontinued Application: 206234

Drug Name

SEVELAMER CARBONATE

Product Number

1

Dosage Form

-

Strength

800MG/PACKET

Approval Date

2024-07-12

206234 / 1

Active Ingredient

SEVELAMER CARBONATE

Application Number

206234

Product Number

1

Dosage Form

-

Strength

800MG/PACKET

Approval Date

2024-07-12

Regulatory Status

Discontinued

2024
12 Jul
Discontinued Application: 206234

Drug Name

SEVELAMER CARBONATE

Product Number

2

Dosage Form

-

Strength

2.4GM/PACKET

Approval Date

2024-07-12

206234 / 2

Active Ingredient

SEVELAMER CARBONATE

Application Number

206234

Product Number

2

Dosage Form

-

Strength

2.4GM/PACKET

Approval Date

2024-07-12

Regulatory Status

Discontinued

2007
02 Jul
Discontinued Application: 77533

Drug Name

TERBINAFINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2007-07-02

77533 / 1

Active Ingredient

TERBINAFINE HYDROCHLORIDE

Application Number

77533

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2007-07-02

Regulatory Status

Discontinued

2007
12 Jun
Discontinued Application: 78320

Drug Name

TRANDOLAPRIL

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2007-06-12

78320 / 1

Active Ingredient

TRANDOLAPRIL

Application Number

78320

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2007-06-12

Regulatory Status

Discontinued

2007
12 Jun
Discontinued Application: 78320

Drug Name

TRANDOLAPRIL

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2007-06-12

78320 / 2

Active Ingredient

TRANDOLAPRIL

Application Number

78320

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2007-06-12

Regulatory Status

Discontinued

2007
12 Jun
Discontinued Application: 78320

Drug Name

TRANDOLAPRIL

Product Number

3

Dosage Form

-

Strength

4MG

Approval Date

2007-06-12

78320 / 3

Active Ingredient

TRANDOLAPRIL

Application Number

78320

Product Number

3

Dosage Form

-

Strength

4MG

Approval Date

2007-06-12

Regulatory Status

Discontinued

2014
09 Apr
Discontinued Application: 204284

Drug Name

ZOLMITRIPTAN

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2014-04-09

204284 / 1

Active Ingredient

ZOLMITRIPTAN

Application Number

204284

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2014-04-09

Regulatory Status

Discontinued

2014
09 Apr
Discontinued Application: 204284

Drug Name

ZOLMITRIPTAN

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2014-04-09

204284 / 2

Active Ingredient

ZOLMITRIPTAN

Application Number

204284

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2014-04-09

Regulatory Status

Discontinued

2007
07 Sep
Discontinued Application: 78184

Drug Name

ZOLPIDEM TARTRATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2007-09-07

78184 / 1

Active Ingredient

ZOLPIDEM TARTRATE

Application Number

78184

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2007-09-07

Regulatory Status

Discontinued

2007
07 Sep
Discontinued Application: 78184

Drug Name

ZOLPIDEM TARTRATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2007-09-07

78184 / 2

Active Ingredient

ZOLPIDEM TARTRATE

Application Number

78184

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2007-09-07

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    170 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
63 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AMANTADINE HYDROCHLORIDE

Application Number

207570

Product Number

1

Active Ingredient

AMANTADINE HYDROCHLORIDE

Dosage Form

-

Strength

100MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit